Sarah James
Stock Analyst at Cantor Fitzgerald
(1.99)
# 3,076
Out of 5,140 analysts
305
Total ratings
35.24%
Success rate
-7%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXG MiMedx Group | Maintains: Overweight | $12 → $8 | $5.17 | +54.74% | 1 | Feb 17, 2026 | |
| HUM Humana | Maintains: Neutral | $290 → $201 | $189.83 | +5.88% | 22 | Feb 12, 2026 | |
| MOH Molina Healthcare | Maintains: Neutral | $180 → $144 | $151.00 | -4.64% | 15 | Feb 9, 2026 | |
| CNC Centene | Reiterates: Neutral | $41 | $43.24 | -5.18% | 17 | Feb 9, 2026 | |
| HCA HCA Healthcare | Maintains: Overweight | $525 → $588 | $532.30 | +10.46% | 22 | Jan 28, 2026 | |
| ACHC Acadia Healthcare Company | Maintains: Neutral | $22 → $17 | $16.79 | +1.25% | 18 | Dec 3, 2025 | |
| CVS CVS Health | Maintains: Overweight | $78 → $95 | $76.69 | +23.88% | 16 | Oct 30, 2025 | |
| UHS Universal Health Services | Maintains: Neutral | $227 → $250 | $230.49 | +8.46% | 27 | Oct 29, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $190 → $245 | $229.90 | +6.57% | 23 | Oct 29, 2025 | |
| SGRY Surgery Partners | Reiterates: Overweight | $36 | $15.54 | +131.66% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $4 | $1.79 | +123.46% | 8 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $440 | $290.00 | +51.72% | 18 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $365 | $280.31 | +30.21% | 22 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $28 | $20.98 | +33.46% | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $485 | $342.93 | +41.43% | 20 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $29 | $20.28 | +43.00% | 6 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $15 | $2.82 | +431.91% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $0.79 | +531.39% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $4.74 | +110.97% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $150.73 | -11.76% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $23.99 | +75.07% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $8.16 | -38.73% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $7.34 | -31.88% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $20.60 | +1.94% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $70.08 | -44.35% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $79.57 | +142.55% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.56 | - | 2 | Mar 1, 2017 |
MiMedx Group
Feb 17, 2026
Maintains: Overweight
Price Target: $12 → $8
Current: $5.17
Upside: +54.74%
Humana
Feb 12, 2026
Maintains: Neutral
Price Target: $290 → $201
Current: $189.83
Upside: +5.88%
Molina Healthcare
Feb 9, 2026
Maintains: Neutral
Price Target: $180 → $144
Current: $151.00
Upside: -4.64%
Centene
Feb 9, 2026
Reiterates: Neutral
Price Target: $41
Current: $43.24
Upside: -5.18%
HCA Healthcare
Jan 28, 2026
Maintains: Overweight
Price Target: $525 → $588
Current: $532.30
Upside: +10.46%
Acadia Healthcare Company
Dec 3, 2025
Maintains: Neutral
Price Target: $22 → $17
Current: $16.79
Upside: +1.25%
CVS Health
Oct 30, 2025
Maintains: Overweight
Price Target: $78 → $95
Current: $76.69
Upside: +23.88%
Universal Health Services
Oct 29, 2025
Maintains: Neutral
Price Target: $227 → $250
Current: $230.49
Upside: +8.46%
Tenet Healthcare
Oct 29, 2025
Maintains: Overweight
Price Target: $190 → $245
Current: $229.90
Upside: +6.57%
Surgery Partners
Oct 7, 2025
Reiterates: Overweight
Price Target: $36
Current: $15.54
Upside: +131.66%
Oct 7, 2025
Reiterates: Neutral
Price Target: $4
Current: $1.79
Upside: +123.46%
Aug 26, 2025
Reiterates: Overweight
Price Target: $440
Current: $290.00
Upside: +51.72%
Aug 26, 2025
Reiterates: Overweight
Price Target: $365
Current: $280.31
Upside: +30.21%
Aug 8, 2025
Maintains: Overweight
Price Target: $26 → $28
Current: $20.98
Upside: +33.46%
Apr 23, 2025
Reiterates: Overweight
Price Target: $485
Current: $342.93
Upside: +41.43%
Mar 11, 2025
Maintains: Overweight
Price Target: $20 → $29
Current: $20.28
Upside: +43.00%
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $2.82
Upside: +431.91%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $0.79
Upside: +531.39%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $4.74
Upside: +110.97%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $150.73
Upside: -11.76%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $23.99
Upside: +75.07%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $8.16
Upside: -38.73%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $7.34
Upside: -31.88%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $20.60
Upside: +1.94%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $70.08
Upside: -44.35%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $79.57
Upside: +142.55%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.56
Upside: -